Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells

被引:16
|
作者
Uemura, Y [1 ]
Kobayashi, M [1 ]
Nakata, H [1 ]
Harada, R [1 ]
Kubota, T [1 ]
Taguchi, H [1 ]
机构
[1] Kochi Med Sch, Dept Internal Med, Nanko Ku, Kochi 7838505, Japan
关键词
serum deprivation; G-CSF; GM-CSF; OKa-C-1; MI-4;
D O I
10.1002/ijc.20023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously established 2 lung cancer cell lines, OKa-C-I and MI-4, which constitutively produce an abundant dose of granulocyte-colony stimulating factor (G-CSF) and granulocyte macrophage-colony stimulating factor (GM-CSF). Many other cases with G-CSF or GM-CSF producing tumors have been reported up to the present. However, the biological properties of the overproduction of G-CSF and GM-CSF by tumor cells have not been well known. Several reports demonstrated the presence of an autocrine growth loop for G- CSF and GM-CSF in nonhematopoietic tumor cells. We showed that exogenous G-CSF and GM-CSF stimulated cell growth in a dose-dependent manner in OKa-C-I and MI-4 cells. We could detect the presence of G-CSF and GM-CSF receptors in both cell lines by RT-PCR analysis. We have previously shown that inflammatory cytokines, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta enhance the expression of G-CSF and GM-CSF in the cell lines. However, the factors that regulate constitutive production of G-CSF or GM-CSF by tumor cells are still unknown well. In our study, we first reported that serum deprivation stimulated constitutive production of G-CSF and GM-CSF by lung tumor cells through activation of nuclear factor (NF)-kappaB and p44/42 mitogen-activated protein kinase (MAPK) pathway signaling. We suggest that G-CSF and GM-CSF constitutively produced by tumor cells could grow tumor itself and rescue tumor cells from the cytotoxicity of serum deprivation. (C) 2004 Wilely-Liss, Inc.
引用
收藏
页码:826 / 832
页数:7
相关论文
共 50 条
  • [21] A novel neuroprotectant granulocyte-colony stimulating factor
    Solaroglu, I
    Cahill, J
    Jadhav, V
    Zhang, JH
    STROKE, 2006, 37 (04) : 1123 - 1128
  • [22] Clinical applications of granulocyte-colony stimulating factor
    Sung, Lillian
    Dror, Yigal
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 1988 - 2002
  • [23] The Role of Granulocyte Macrophage-Colony Stimulating Factor in Gastrointestinal Immunity to Salmonellosis
    Coon, C.
    Beagley, K. W.
    Bao, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 70 (02) : 106 - 115
  • [24] Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis - Is there a role?
    Trapnell, BC
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (02) : 129 - 130
  • [25] INTRACLONAL DIVERSITY OF FIBROSARCOMA CELLS FOR THE PRODUCTION OF MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE COLONY-STIMULATING FACTOR
    SAKAI, N
    KUBOTA, M
    SHIKITA, M
    YOKOTA, M
    ANDO, K
    JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 133 (02) : 400 - 404
  • [26] GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR
    BURGESS, AW
    LYMPHOKINE RESEARCH, 1984, 3 (02): : 64 - 64
  • [27] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR REQUIRES INTERACTION WITH ACCESSORY CELLS OR GRANULOCYTE-COLONY STIMULATING FACTOR FOR FULL STIMULATION OF HUMAN MYELOID PROGENITORS
    FERRERO, D
    TARELLA, C
    BADONI, R
    CARACCIOLO, D
    BELLONE, G
    PILERI, A
    GALLO, E
    BLOOD, 1989, 73 (02) : 402 - 405
  • [28] EFFECT OF GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF) ON LANGERHANS CELLS INVIVO
    SMITH, CH
    GROVES, RW
    ROSS, EL
    BARKER, JNWN
    MACDONALD, DM
    CLINICAL RESEARCH, 1993, 41 (02): : A467 - A467
  • [29] EFFECT OF GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF) ON LANGERHANS CELLS INVIVO
    SMITH, CH
    GROVES, RW
    ROSS, EL
    BARKER, JNWN
    MACDONALD, DM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 490 - 490
  • [30] Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects
    Smith, CH
    Allen, MH
    Groves, RW
    Barker, JNWN
    BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (02) : 239 - 246